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Introduction: A life-threatening hyperinflammatory condition occurring several weeks after primary in-
fection with SARS-CoV-2 that can include severe acute heart failure has been reported in children in early 
2020. Later on, a condition with similar characteristics has also been reported in adults.1,2
Case report: 26-year-old male patient with obesity and arterial hypertension presented to the emergency 
department with 3 days history of fever, chills, dyspnea, exercise intolerance, headache, dry cough, nasal 
discharge and diarrhea approximately six weeks after he has been diagnosed with mild COVID-19. Initial 
blood tests showed markedly elevated laboratory inflammatory markers. CT scan showed enlarged lymph 
nodes in the neck and small areas of residual ground-glass opacities in the lungs. Pulmonary thrombo-
embolism was ruled out. He was admitted to the infectious disease clinic and was started on cloxacillin, 
ceftriaxone, antipyretics and appropriate rehydration. On the third day of hospital treatment, the patient 
complained of chest and neck pain and severe dyspnea. His general condition deteriorated rapidly, and 
he was transferred to the intensive care unit due to the development of cardiogenic shock. Inotropic and 
vasopressor support was initiated. Echocardiography showed mildly dilated left ventricle with severe im-
pairment of global systolic function (LVEF 20 %). High-sensitivity troponin I and NT-proBNP were mark-
edly elevated with a peak concentration of 792 
and 18200 ng/l, respectively. Therefore, the 
patient was transferred to the tertiary center 
coronary care unit (CCU). Pulse steroid thera-
py and intravenous immunoglobulin were im-
mediately initiated, while heart failure thera-
py was gradually introduced in the following 
days. Seven days after admission to CCU, 
multiparametric cardiac magnetic resonance 
imaging (MRI) revealed preserved LVEF with 
diffusely prolonged myocardial T1 relaxation 
time and T2 relaxation time, confirming myo-
cardial injury and edema, respectively. There 
was no late gadolinium enhancement (Figure 
1). Updated Lake-Louise criteria for myocardi-
tis have been fulfilled.3 The following criteria 
for multisystem inflammatory syndrome in 
adults (MIS-A) were met: age over 21 years, a 
positive test result for previous SARS-CoV-2 
infection, documented fever >38.0°C for ≥24 
hours, laboratory evidence of inflammation, involvement of cardiovascular and gastrointestinal system, 
and severe illness requiring hospitalization.
Conclusion: This case indicates that there is a vast diversity of clinical presentation and underlying 
mechanisms of COVID-19 and post-COVID-19 syndromes with myocardial injury. Recently described 
MIS-A is a rare but potentially life-threatening complication of previous SARS-CoV-2 infection. Clinicians 
should be aware of this syndrome in order to recognize it on time and start with appropriate treatment. 
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Figure 1. Cardiac magnetic resonance imaging (MRI) findings; Multiparametric cardiac 
MRI revealed preserved left ventricular ejection fraction with diffusely prolonged myocar-
dial T1 relaxation time (1058 ms, normal values 954-1042 ms, A) and T2 relaxation time 
(49,0 ms, normal values <47,5 ms, B), confirming myocardial injury and edema, respecti-
vely. There was no late gadolinium enhancement (C). There was left ventricular concentric 
symmetric myocardial hypertrophy with myocardial thickness of 15 mm.
LV- left ventricle, RV- right ventricle.
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